Meanwhile, Yu et al. described that FEZF1 was an independent biomarker to predict reduced survival in gliomas and that FEZF1 promoted proliferation, migration and invasion of glioma cells in vitro [43]. Here, FEZF1 is linked to central nervous system cancer.